RecruitingNCT06906003

Visual Rehabilitation and Depression in Visually Impaired Patients with AMD

Evaluation of the Impact of Visual Rehabilitation on Anxiety and Depression Severity of Visually Impaired Patients with Advanced Age Related Macular Degeneration

Sponsor

Fondazione G.B. Bietti, IRCCS

Enrollment

22 participants

Start Date

Dec 2, 2024

Study Type

OBSERVATIONAL

Conditions

Anxiety Depression Disorders AMD - Age-Related Macular Degeneration

Summary

Purpose: The aim of this study is to evaluate the impact of visual rehabilitation in visually impaired patients with advanced AMD by the use of questionnaires on the anxiety and depression status. Study design: prospective observational study. The study is carried out at the IRCCS Fondazione G.B.Bietti and at the UO Visual Rehabilitation, S. Alessio - Margherita di Savoia. Study procedures: Visit 1 (screening visit, at IRCCS Fondazione Bietti) After signing the informed consent, all patients received a complete ophthalmological examination, non-invasive diagnostic tests as optical coherence tomography, autofluorescence and microperimetry, and have to complete the questionnaires on the state of anxiety and depression (GAD-7 and PHQ-9). Visit 2 (at the Sant'Alessio Institute) for a 60-day visual rehabilitation program scheduled in 5 group meetings. Visit 3 (end-of-study visit, at IRCCS Fondazione G.B. Bietti) complete ophthalmological examination, as per clinical practice, non-invasive diagnostic tests such as microperimetry, optical coherence tomography and autofluorescence and administration of the Patient Health Questionnaire-9 (PHQ-9) questionnaires for depression and the General Anxiety Disorder (GAD-7) questionnaires for anxiety.

Eligibility

Min Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether a structured visual rehabilitation program can reduce depression in older adults with significant vision loss due to advanced dry age-related macular degeneration (AMD) — a common cause of vision loss in older people where the central part of vision deteriorates. **You may be eligible if...** - You are 55 years old or older - You have moderate to severe vision impairment (best corrected visual acuity between 1/10 and 2/10) - You have been diagnosed with advanced non-wet (non-exudative) age-related macular degeneration - You are able to understand and follow study instructions **You may NOT be eligible if...** - Your vision loss is caused by a different eye disease - Your vision is only mildly impaired, or you have total or near-total blindness - You have the wet form of AMD and are currently receiving injections into the eye Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERvisual rehabilitation program

I. meeting: coin recognition II. meeting: reading stories and audio books' listening III. meeting: installation of APPs on their smartphones and tablets and use of voice assistant IV. meeting: management of "table" activities V. meeting: meeting with caregivers.